{
 "PrintNo":"S4677","Session":2023,"Chamber":"SENATE","BillType":"Senate","Published":"2023-02-13T14:00:02.431486Z",
 "Status":"IN_SENATE_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_SENATE_COMM","Date":"2024-01-03","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO HEALTH","Date":"2023-02-13","Chamber":"SENATE"},
  {"Text":"REFERRED TO HEALTH","Date":"2024-01-03","Chamber":"SENATE"}
 ],
 "Sponsors":[{"ID":416,"Name":"Kevin S. Parker","Short":"PARKER"},{"ID":384,"Name":"Joseph P. Addabbo Jr.","Short":"ADDABBO"}],
 "Title":"Authorizes and directs the department of health to conduct a study on drugs prescribed for school age children with ADD and ADHD",
 "Summary":"Authorizes and directs the department of health to conduct a study on drugs prescribed for school-age children with ADD and ADHD.",
 "LawSection":"Health, Commissioner of",
 "ActClause":"AN ACT authorizing and directing the department of health to do research and study as to the effects of psychostimulants, selective seratonin reuptake inhibitors, antidepressants and other drugs which are prescribed for attention deficit disorders, ADD and ADHD, for school age children",
 "SameAsPrintNo":"A1969-2023",
 "PreviousVersions":["S8202-2009","S1172-2011","S3100-2013","S2761-2015","S2193-2017","S2599-2019","S3167-2021"]
}